Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

235 projects found matching your search criteria :

  1. Individual biological response of breast cancer tumours to proton irradiation in correlation with molecular and microenv...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Julian Czesław Malicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  2. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. Molecular mechanism underlying the anti-inflammatory action of CB2 receptor agonists in microglia: participation of the ...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Natalia Eleonora Małek-Chudzik

    Politechnika Wrocławska

  4. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

  5. Hybrid isothermal annealing as innovative heat treatment of nanobainitic multiphase steels with yield strength > 1GPa

    Call: PRELUDIUM 20 , Panel: ST8

    Principal investigator: Mateusz Morawiec

    Politechnika Śląska, Wydział Mechaniczny Technologiczny

  6. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marta Kędziora

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. 3D printing as a tool to obtain transdermal microneedle systems with improved efficiency in the treatment of depressive ...

    Call: SONATA BIS 11 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Zbigniew Osmałek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  8. The relationship between hostile attributions and personality disorders symptoms: contextual and cognitive underpinnings...

    Call: SONATA BIS 11 , Panel: HS6

    Principal investigator: dr hab. Anna Maria Zajenkowska

    Akademia Ekonomiczno-Humanistyczna w Warszawie

  9. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

  10. Flexible, stretchable and antibacterial curdlan-tannin dressing for the prevention and treatment of infected wounds - in...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: dr Anna Maria Michalicha

    Uniwersytet Medyczny w Lublinie

  11. The Role of the Mitochondrial Unfolded Protein Response (UPRmt) in Endothelial Function: a Possible Novel Target for the...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Sylwester Mosiołek

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  12. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  13. Nanomolecular antioxidants: biological basis of targeted therapy of neurodegenerative diseases.

    Call: SONATA BIS 6 , Panel: NZ7

    Principal investigator: dr hab. Izabela Sadowska-Bartosz

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  14. Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for ...

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Hanna Piotrowska-Kempisty

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  15. The role of neurotrophins and angiogenic cytokines in the pathophysiology of treatment-induced peripheral neuropathy in ...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Bogusław Machaliński

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Medycyny i Stomatologii

  16. Contribution of PHLDA1 to response of neuroblastoma cells to clinical and experimental ways of treatment of high-risk ne...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: prof. Hanna Rokita

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  17. The influence of low-temperature annealing on the nanostructure evolution and properties of hexagonal Ti with diversifie...

    Call: OPUS 15 , Panel: ST8

    Principal investigator: prof. Halina Garbacz

    Politechnika Warszawska, Wydział Inżynierii Materiałowej

  18. Novel dual PDE4 and PDE7 inhibitors in a group of purine and deazapurine derivatives - perspective for the treatment of ...

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Maciej Pawłowski

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  19. Towards the understanding of neuronal mechanisms of compulsive sexual behaviors.

    Call: OPUS 8 , Panel: HS6

    Principal investigator: dr Mateusz Gola

    Instytut Psychologii PAN

  20. Identification of biomarkers of individual radiochemotherapy toxicity and efficacy in patients with head and neck cancer...

    Call: OPUS 9 , Panel: NZ5

    Principal investigator: prof. Krzysztof Składowski

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

  21. Drinking water treatment residue as an amendment for sewage sludge used as a pretreatment for their safe utilization for...

    Call: PRELUDIUM 11 , Panel: ST10

    Principal investigator: Rafał Gałązka

    Instytut Uprawy Nawożenia i Gleboznawstwa - Państwowy Instytut Badawczy

  22. Importance of cyclin F-RRM2 axis in drug-resistance of melanoma cells with different degree of aggressiveness - in vitro...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Alina Grzanka

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Lekarski

  23. Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr Małgorzata Firczuk

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  24. Evaluation of the sorption abilities of lignocellulosic materials dedicated to the removal of selected inorganic and org...

    Call: PRELUDIUM 5 , Panel: ST8

    Principal investigator: Przemysław Bartczak

    Politechnika Poznańska, Wydział Technologii Chemicznej

  25. Analysis of phase transformations accompanying decomposition of ausferrite in copper-nickel ADI, obtained in cyclic ausf...

    Call: OPUS 5 , Panel: ST8

    Principal investigator: dr Andrzej Gazda

    Instytut Odlewnictwa

  26. Pharmacokinetic profiling to understand differences in biological activity of two novel liver-selective NO-releasing com...

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: dr Kamil Kuś

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  27. Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment: study on the novel genet...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

  28. A new generation of scaffolds based on curdlan and whey protein isolate obtained by electrospinning for the treatment of...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Katarzyna Klimek

    Uniwersytet Medyczny w Lublinie

  29. Application of superparamagnetic iron oxide nanoparticles (SPION) in inhaled theranostic systems containing antifungal d...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Gabriela Wyszogrodzka-Gaweł

    Uniwersytet Jagielloński, Collegium Medicum

  30. PROteolysis TArgeting Chimeras (PROTACs) intended to knock down excessive amyloidogenic proteins, human islet amyloid po...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Elżbieta Jankowska

    Uniwersytet Gdański, Wydział Chemii

  31. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Joanna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  32. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  33. Cellular senescence as a new mechanism in development and progression of head and neck cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: prof. Michał Masternak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  34. Chemopreventive potential of melanoidins isolated from heated potato fiber Potex. An in vitro study in colon carcinoma c...

    Call: PRELUDIUM 1 , Panel: NZ5

    Principal investigator: Ewa Langner

    Instytut Medycyny Wsi im. Witolda Chodźki

  35. The research of the municipal sewage sludge thermal treatment influence on the physico-chemical properties of ash

    Call: SONATA 2 , Panel: ST8

    Principal investigator: dr Jolanta Latosińska

    Politechnika Świętokrzyska, Wydział Inżynierii Środowiska, Geomatyki i Energetyki

  36. Optimization of analytical methods in order to apply them to determination of water-soluble vitamins in ultrafiltrates o...

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: Dorota Wirkus

    Uniwersytet Gdański, Wydział Chemii

  37. Novel peptide inhibitors of dipeptidyl peptidase IV (DPP IV) as novel approach for diabetes type 2 and inflammatory bowe...

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: Maciej Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  38. Endogenous enkephalinase inhibitors and their novel synthetic analogs as potential new therapeutics for the treatment of...

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jakub Fichna

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  39. Endogenny układ opioidowy i nocyceptynowy jako potencjalne cele farmakologiczne dla terapeutyków działających w układzie...

    Call: ETIUDA 2 , Panel: NZ7

    Principal investigator: dr Marta Zielińska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  40. Investigation of the relationship between telomerase activity and the mechanism of cell death induction in head and neck...

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Wojciech Barczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  41. Verification of the hypothesis of oxidative stress, apoptosis and immune factor as the mechanisms responsible for the po...

    Call: OPUS 10 , Panel: NZ5

    Principal investigator: dr hab. Monika Frączek

    Instytut Genetyki Człowieka Polskiej Akademii Nauk

  42. The importance of interaction between NMDA and AMPA receptors and scaffolding proteins in the excitatory synaptic in the...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr hab. Magdalena Sowa-Kućma

    Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

  43. New amide derivatives of cinnamic acid as a carbonyl reductase inhibitors, which modulate the activity of doxorubicin - ...

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Paulina Koczurkiewicz-Adamczyk

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  44. Projektowanie, synteza oraz badanie aktywności biologicznej nowych amidosiarczanowych inhibitorów sulfatazy steroidowej ...

    Call: ETIUDA 5 , Panel: NZ7

    Principal investigator: Mateusz Daśko

    Politechnika Gdańska, Wydział Chemiczny

  45. CBR1-dependent metabolism and ABCB1-dependent effux of doxorubicin - search for a novel mechanism of reversing resistanc...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: Kamil Piska

    Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  46. Addressing the brain glioma temozolomide therapy limitations

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr hab. Joanna Małgorzata Lewandowska-Łańcucka

    Uniwersytet Jagielloński, Wydział Chemii

  47. The origin, transformations and influence of particulate matter and selectedorganic compounds in the air of beauty salon...

    Call: OPUS 21 , Panel: ST10

    Principal investigator: dr Patrycja Kornelia Rogula-Kopiec

    Instytut Podstaw Inżynierii Środowiska Polskiej Akademii Nauk

  48. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  49. Evaluation of NOTCH1- and NOTCH3-dependent anticancer drug resistance in a 2D and 3D model of Head and Neck Squamous Cel...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: dr Joanna Elżbieta Kałafut

    Uniwersytet Medyczny w Lublinie

  50. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of ...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk